CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 282 filers reported holding CYTOKINETICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,506,854 | -11.4% | 27,812 | +14.7% | 0.01% | -16.7% |
Q1 2024 | $1,700,378 | -15.7% | 24,253 | +0.4% | 0.01% | -20.0% |
Q4 2023 | $2,016,450 | +164.6% | 24,152 | -6.6% | 0.02% | +150.0% |
Q3 2023 | $762,130 | -8.4% | 25,870 | +1.4% | 0.01% | -14.3% |
Q2 2023 | $832,038 | -9.2% | 25,507 | -2.1% | 0.01% | -12.5% |
Q1 2023 | $916,629 | -20.7% | 26,048 | +3.2% | 0.01% | -27.3% |
Q4 2022 | $1,156,359 | +8.0% | 25,237 | +14.1% | 0.01% | 0.0% |
Q3 2022 | $1,071,000 | +26.1% | 22,112 | +2.4% | 0.01% | +37.5% |
Q2 2022 | $849,000 | +13.0% | 21,596 | +5.8% | 0.01% | +33.3% |
Q1 2022 | $751,000 | -18.5% | 20,407 | +0.9% | 0.01% | -14.3% |
Q4 2021 | $922,000 | +28.8% | 20,229 | +1.0% | 0.01% | +16.7% |
Q3 2021 | $716,000 | +134.8% | 20,038 | +30.2% | 0.01% | +200.0% |
Q2 2021 | $305,000 | -29.2% | 15,392 | -17.0% | 0.00% | -50.0% |
Q1 2021 | $431,000 | +12.8% | 18,543 | +0.8% | 0.00% | +33.3% |
Q4 2020 | $382,000 | -2.8% | 18,402 | +1.5% | 0.00% | -25.0% |
Q3 2020 | $393,000 | +47.2% | 18,130 | +59.9% | 0.00% | 0.0% |
Q2 2020 | $267,000 | +92.1% | 11,335 | -3.9% | 0.00% | +100.0% |
Q1 2020 | $139,000 | -66.7% | 11,790 | -70.1% | 0.00% | -60.0% |
Q4 2019 | $418,000 | -46.7% | 39,398 | -42.8% | 0.01% | -50.0% |
Q3 2019 | $784,000 | -22.1% | 68,917 | -23.0% | 0.01% | -16.7% |
Q2 2019 | $1,007,000 | +47.4% | 89,538 | +6.1% | 0.01% | +50.0% |
Q1 2019 | $683,000 | +28.4% | 84,399 | +0.2% | 0.01% | +14.3% |
Q4 2018 | $532,000 | -31.9% | 84,254 | +6.3% | 0.01% | 0.0% |
Q3 2018 | $781,000 | +26.8% | 79,245 | +6.8% | 0.01% | +16.7% |
Q2 2018 | $616,000 | +6.9% | 74,188 | -7.2% | 0.01% | 0.0% |
Q1 2018 | $576,000 | -17.0% | 79,934 | -6.1% | 0.01% | -14.3% |
Q4 2017 | $694,000 | +82.6% | 85,134 | +224.9% | 0.01% | +40.0% |
Q3 2017 | $380,000 | +30.1% | 26,200 | +8.6% | 0.01% | +25.0% |
Q2 2017 | $292,000 | – | 24,130 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |